Brendan W. Merrell's most recent trade in OptimizeRx Corp was a trade of 289 Common Stock done at an average price of $13.5 . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Brendan W. Merrell | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 19 Dec 2025 | 289 | 26,207 (0%) | 0% | 13.5 | 3,904 | Common Stock |
| OptimizeRx Corp | Brendan W. Merrell | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.03 per share. | 11 Dec 2025 | 712 | 26,496 (0%) | 0% | 14.0 | 9,989 | Common Stock |
| OptimizeRx Corp | Brendan W. Merrell | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2025 | 23,437 | 46,874 | - | - | Stock Option | |
| OptimizeRx Corp | Brendan W. Merrell | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2025 | 10,417 | 27,691 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Brendan W. Merrell | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.75 per share. | 21 Aug 2025 | 483 | 27,208 (0%) | 0% | 18.7 | 9,056 | Common Stock |